The social context of drinking among LGBT+ people
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
Join as an individual or organization
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
In this research, the authors explored how lesbian, gay, bisexual, transgender, and queer (LGBTQ) young adults with problematic substance use made sense of their substance use in relation to their LGBTQ identities.
The authors interviewed...
This briefing provides a summary of alcohol consumption, alcohol harm, alcohol treatment, and gaps in knowledge regarding alcohol use among LGBTQ+ people.
It uses the acronym LGBTQ+ to include lesbian, gay, bisexual, transgender, queer...
Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) Pride month is celebrated each year during the month of June. Here you can find a list of resources and research on the topic of substance use among the LGBTQ+ community.
1) This repor...
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...
با وجود شواهد گسترده در مورد اثرات منفی ننگ تجربه شده توسط افراد مبتلا به اچ آی وی (PLHIV) و افرادی که تزریق مواد مخدر در تنظیمات مراقبت های بهداشتی، شواهد نسبتا کمی در مورد اثر ابتکارات برای کاهش این ننگ وجود دارد.
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
ارائه شده توسط ریچارد راوسون، دکترا، استاد برجسته در گروه روانپزشکی و علوم رفتاری زیستی، دانشکده پزشکی دانشگاه کالیفرنیا و استاد تحقیقات در دانشگاه ورمانت، این ارائه ارائه یک مرور کلی از دانش فعلی در مورد مشکل استفاده از محرک (کوکائین و مت...
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network has been launched!
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
بحران استفاده از مواد مخدر فشار بر منابع در ایالات متحده و در سراسر جهان قرار می دهد. 3 داروی مورد تایید سازمان غذا و داروی آمریکا برای درمان اختلال مصرف مواد مخدر وجود دارد: متادن، بوپرنرفین، و نالترکسون آزاد شده تزریقی (XR...
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Cocaine is an addictive stimulant drug that originates from the leaves of the coca plant, which is indigenous to South America. The drug's effects include heightened alertness, attention, and energy, as well as feelings of euphoria and...
The markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available.
The European situation presented in Section 1 can...
هدف: برای درک بهتر تحولات فعلی در درمان استفاده از محرک.
سابقه و هدف: داروهای محرک به عنوان پرکاربردترين طبقه مواد مخدر در سطح جهان، که 68 ميليون مصرف کننده در سال گذشته را در بر می گیرد، در درجه دوم قرار دارند.
در اروپا، بر اساس آخرین...